| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/PGS.09.121 |
| P698 | PubMed publication ID | 19891557 |
| P50 | author | Chloe L Thio | Q92964327 |
| Pierre-Yves Bochud | Q50877821 | ||
| Silvana Gaudieri | Q89100814 | ||
| Andri Rauch | Q92034483 | ||
| P2860 | cites work | Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research | Q22010973 |
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 | ||
| Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus | Q27469800 | ||
| Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection | Q27472839 | ||
| HLA-Cw*04 and hepatitis C virus persistence | Q27472874 | ||
| Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection | Q27472915 | ||
| A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades | Q27473000 | ||
| Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease | Q27473001 | ||
| The CCR5- 32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source | Q27477986 | ||
| Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia | Q27480307 | ||
| CD8 Epitope Escape and Reversion in Acute HCV Infection | Q27485189 | ||
| Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man | Q27485215 | ||
| Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome | Q27486089 | ||
| Interferon-inducible antiviral effectors | Q27486790 | ||
| Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus | Q27487445 | ||
| Regulatory Polymorphisms in the Interleukin‐18 Promoter Are Associated with Hepatitis C Virus Clearance | Q27488349 | ||
| Genetic Markers of IgG Influence the Outcome of Infection with Hepatitis C Virus | Q27488362 | ||
| Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection | Q27488372 | ||
| Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans | Q27489728 | ||
| MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment | Q27860726 | ||
| Replication of hepatitis C virus | Q27860957 | ||
| Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
| HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage | Q28138607 | ||
| The influence of HLA genotype on AIDS | Q28202903 | ||
| MHC class II genes influence the susceptibility to chronic active hepatitis C | Q28248437 | ||
| Genetic variations in humans associated with differences in the course of hepatitis C | Q28254610 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 | ||
| Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons | Q28274676 | ||
| A comparative review of HLA associations with hepatitis B and C viral infections across global populations | Q28299722 | ||
| Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease | Q29614208 | ||
| Common genetic variation and human traits | Q29614445 | ||
| Interleukin-12 and the regulation of innate resistance and adaptive immunity | Q29614602 | ||
| A whole-genome association study of major determinants for host control of HIV-1 | Q29614891 | ||
| Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization | Q29615898 | ||
| Immunology of hepatitis B virus and hepatitis C virus infection | Q29618957 | ||
| Evasion of intracellular host defence by hepatitis C virus | Q29618976 | ||
| Adaptive immune responses in acute and chronic hepatitis C virus infection | Q29619722 | ||
| Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C | Q29620614 | ||
| HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help | Q29620766 | ||
| Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection | Q29620795 | ||
| Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response | Q29620891 | ||
| Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment | Q31122023 | ||
| Missingness in the T1DGC MHC fine-mapping SNP data: association with HLA genotype and potential influence on genetic association studies | Q33399899 | ||
| Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip | Q33459119 | ||
| Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease | Q33630704 | ||
| Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection | Q33853655 | ||
| Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study | Q33967148 | ||
| Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection | Q33974291 | ||
| The natural history of hepatitis C virus infection: host, viral, and environmental factors | Q33974693 | ||
| High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives | Q33993892 | ||
| Global challenges in liver disease | Q33999114 | ||
| Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir | Q34117815 | ||
| The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences | Q34200151 | ||
| Immunity to hepatitis C virus: stunned but not defeated | Q34515852 | ||
| Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates | Q34604833 | ||
| Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection | Q34700869 | ||
| Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy | Q34797664 | ||
| Follow-up studies of treatment for hepatitis C virus infection among injection drug users | Q42991341 | ||
| Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance | Q42991714 | ||
| Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group | Q42993140 | ||
| Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. | Q42993377 | ||
| Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years | Q42995243 | ||
| Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution | Q42998504 | ||
| Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population | Q42998786 | ||
| HLA-C and KIR genes in hepatitis C virus infection. | Q42999215 | ||
| Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus | Q42999490 | ||
| Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance | Q43000404 | ||
| Hepatitis C virus clearance is prominent in women in an endemic area | Q43000829 | ||
| Racial differences in HLA class II associations with hepatitis C virus outcomes | Q43032027 | ||
| Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers | Q43032783 | ||
| Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? | Q43036063 | ||
| Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection | Q43037291 | ||
| Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis | Q43037726 | ||
| Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population | Q43038195 | ||
| Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection | Q43039746 | ||
| Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. | Q43046800 | ||
| Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection | Q43438665 | ||
| An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes | Q43491662 | ||
| Surprisingly small effect of antiviral treatment in patients with hepatitis C. | Q43889137 | ||
| Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. | Q44291572 | ||
| HCV chronic infection and CCR5-delta32/delta32. | Q44350295 | ||
| Polymorphisms in the IL-12B gene and outcome of HCV infection | Q44752498 | ||
| Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection. | Q44865251 | ||
| Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes. | Q45399299 | ||
| Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T cells | Q45399738 | ||
| Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection | Q45400167 | ||
| Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection | Q45402052 | ||
| Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection. | Q45413597 | ||
| Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population | Q45421753 | ||
| RIGing a virus trap | Q45424053 | ||
| Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection | Q45569965 | ||
| Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection | Q45722071 | ||
| Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons | Q45760124 | ||
| HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders | Q45766137 | ||
| High frequency of CCR5-delta32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1. | Q45858918 | ||
| Maintenance of MHC polymorphism | Q47864601 | ||
| The reverse stop-signal model for CTLA4 function. | Q48540784 | ||
| Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin. | Q50579778 | ||
| Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. | Q50582782 | ||
| Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. | Q50585022 | ||
| Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. | Q51922292 | ||
| Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. | Q52039136 | ||
| IL-10 and TNF-α polymorphisms and the recovery from HCV infection | Q58803426 | ||
| Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism | Q35024327 | ||
| A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection | Q35612409 | ||
| Host genetic determinants in hepatitis C virus infection | Q35753723 | ||
| Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt | Q35956085 | ||
| Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses | Q35988436 | ||
| Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection | Q36076518 | ||
| T cells and viral persistence: lessons from diverse infections | Q36238129 | ||
| Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies | Q36346436 | ||
| Type 1 interferons and the virus-host relationship: a lesson in détente . | Q36475884 | ||
| Flying under the radar: the immunobiology of hepatitis C. | Q36635544 | ||
| Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection | Q36710738 | ||
| Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C. | Q36733943 | ||
| Altered innate immunity in chronic hepatitis C infection: cause or effect? | Q36948514 | ||
| Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation | Q37130676 | ||
| Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant | Q37356747 | ||
| Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. | Q37381208 | ||
| Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus | Q37423211 | ||
| Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study | Q38462606 | ||
| Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II. | Q39149612 | ||
| Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure | Q39956342 | ||
| Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy | Q40626254 | ||
| Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling | Q40662613 | ||
| Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection | Q41604090 | ||
| Protective KIR-HLA interactions for HCV infection in intravenous drug users. | Q41903533 | ||
| High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection | Q42635673 | ||
| Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells | Q42978974 | ||
| IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection | Q42982169 | ||
| Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells | Q42982580 | ||
| Epidemiology and risk factors for hepatitis C in Alaska Natives | Q42982924 | ||
| An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection | Q42984292 | ||
| Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia. | Q42984759 | ||
| Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source | Q42986139 | ||
| Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. | Q42986154 | ||
| HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection | Q42986755 | ||
| Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. | Q42987325 | ||
| Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group | Q42988856 | ||
| Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes | Q42990497 | ||
| P433 | issue | 11 | |
| P921 | main subject | hepatitis C | Q154869 |
| P304 | page(s) | 1819-1837 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Host genetic determinants of spontaneous hepatitis C clearance | |
| P478 | volume | 10 |
| Q35356926 | A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection. |
| Q31066011 | Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus |
| Q52589250 | Association between human leucocyte antigen-DO polymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study. |
| Q28534715 | Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infection |
| Q47108259 | Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C. |
| Q36194392 | Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins |
| Q45360519 | Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. |
| Q36535789 | Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C. |
| Q37683126 | Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C |
| Q33912466 | Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients |
| Q35083980 | Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance |
| Q42256995 | Functional polymorphisms of TLR8 are associated with hepatitis C virus infection |
| Q34787490 | Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study |
| Q40104336 | Genetic variations in toll-like receptors 7 and 8 modulate natural hepatitis C outcomes and liver disease progression. |
| Q42917996 | Genetics of spontaneous clearance of hepatitis C virus infection: a complex topic with much to learn. |
| Q37857571 | Genome-wide association studies and susceptibility to infectious diseases |
| Q35374519 | HLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors |
| Q33735206 | Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection |
| Q26862729 | Hepatitis C virus adaptation to T-cell immune pressure |
| Q36717008 | Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine |
| Q37781667 | Host genetic basis for hepatitis C virus clearance: a role for blood collection centers |
| Q37862746 | Host genetics in immune-mediated hepatitis C virus clearance |
| Q38740771 | Host-virus interactions in hepatitis B and hepatitis C infection |
| Q37216063 | IFN-λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection |
| Q34287407 | IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population |
| Q38334024 | Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees. |
| Q43864701 | Impact of interleukin 28B polymorphisms on spontaneous clearance of hepatitis C virus infection: a meta-analysis |
| Q26999264 | Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines |
| Q28087595 | Influence of host resistance on viral adaptation: hepatitis C virus as a case study |
| Q43038060 | Innate and adaptive immunity shape circulating HCV strains |
| Q37613481 | Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making |
| Q40995329 | Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population. |
| Q33759224 | Protective immunity against hepatitis C: many shades of gray. |
| Q41740477 | Single nucleotide polymorphisms of toll-like receptor 7 in hepatitis C virus infection patients from a high-risk chinese population |
| Q34493947 | Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes |
| Q34056191 | TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection |
| Q41216716 | The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran. |
| Q34575747 | The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation |
| Q37997042 | The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment |
| Q37855530 | Treatment of acute HCV infection |
| Q37528605 | Type III Interferons in Hepatitis C Virus Infection. |
| Q35839496 | Update on hepatitis C virus-specific immunity |
Search more.